Published in J Virol on June 01, 1986
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol (1989) 8.68
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J (1989) 6.60
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J Virol (1987) 3.24
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol (1989) 3.02
The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol (1987) 2.90
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol (1989) 2.17
Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol (1996) 2.03
Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J Virol (1988) 1.97
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J (1994) 1.71
Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J Virol (1988) 1.70
Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity. J Virol (1989) 1.64
Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol (1988) 1.63
Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol (1987) 1.54
Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation. J Virol (1989) 1.52
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol (1997) 1.41
Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol (1990) 1.21
Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer (1987) 1.15
Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol (1988) 1.12
Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol (2003) 1.11
Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol (1997) 1.06
The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication. J Virol (1998) 0.99
The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J Cancer Res Clin Oncol (2008) 0.98
Topography of early HPV 16 transcription in high-grade genital precancers. Am J Pathol (1989) 0.98
Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses. J Virol (1998) 0.94
A viral-cellular junction fragment from a human papillomavirus type 16-positive tumor is competent in transformation of NIH 3T3 cells. J Virol (1988) 0.88
Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA. J Virol (1988) 0.84
Progression of the phenotype of transformed cells after growth stimulation of cells by a human papillomavirus type 16 gene function. J Virol (1988) 0.81
Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer (2016) 0.75
The HPV 16 genome induces carcinomas and T-cell lymphomas in transgenic mice. Am J Pathol (1995) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
New M13 vectors for cloning. Methods Enzymol (1983) 90.74
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Ubiquitous, interspersed repeated sequences in mammalian genomes. Proc Natl Acad Sci U S A (1980) 9.48
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
The primary structure and genetic organization of the bovine papillomavirus type 1 genome. Nature (1982) 7.24
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J (1982) 4.13
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology (1985) 3.22
Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol (1985) 2.70
Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. Proc Natl Acad Sci U S A (1982) 2.65
Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proc Natl Acad Sci U S A (1985) 2.48
Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas. Jpn J Cancer Res (1985) 1.24
DNA rearrangement in the control region for early transcription in a human polyomavirus JC host range mutant capable of growing in human embryonic kidney cells. J Virol (1985) 1.08
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region. Nucleic Acids Res (1985) 4.56
Regulation of DNA-replication origins during cell-cycle progression. Nature (1998) 4.52
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology (2004) 4.24
Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol (1986) 3.90
The chromosome of Bacillus subtilis. I. Theory of marker frequency analysis. Genetics (1965) 3.75
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Nucleotide sequence of the major early region of bacteriophage phi 29. Gene (1982) 3.26
DNA synthesis during germination of Bacillus subtilis spores. Proc Natl Acad Sci U S A (1965) 3.09
Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. Nat Biotechnol (2000) 3.09
Studies on DNA from low-density particles of SV40. I. Heterogeneous defective virions produced by successive undiluted passages. Virology (1968) 2.99
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet (1999) 2.71
Systematic sequencing of the 180 kilobase region of the Bacillus subtilis chromosome containing the replication origin. DNA Res (1994) 2.70
Unbinding force of a single motor molecule of muscle measured using optical tweezers. Nature (1995) 2.64
Cloning and nucleotide sequence of phoP, the regulatory gene for alkaline phosphatase and phosphodiesterase in Bacillus subtilis. J Bacteriol (1987) 2.52
Structure and organization of rRNA operons in the region of the replication origin of the Bacillus subtilis chromosome. Nucleic Acids Res (1983) 2.40
Genes and their organization in the replication origin region of the bacterial chromosome. Mol Microbiol (1992) 2.39
The efficiency and timing of initiation of replication of multiple replicons of Saccharomyces cerevisiae chromosome VI. Genes Cells (1997) 2.38
Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha. Circulation (2001) 2.36
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol (1985) 2.24
Retracted A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J (2001) 2.21
Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol (1989) 2.17
ParaSight-F test for the detection of treatment failure in multidrug resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1996) 2.13
Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. Virology (1988) 2.11
Stepwise motion of an actin filament over a small number of heavy meromyosin molecules is revealed in an in vitro motility assay. J Biochem (1994) 2.11
Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother (1989) 2.05
In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA. Proc Natl Acad Sci U S A (1991) 2.03
Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients. Osteoporos Int (2014) 2.03
Nucleotide sequence of the Bacillus subtilis phoR gene. J Bacteriol (1988) 2.02
Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res (1991) 1.99
Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J Virol (1988) 1.97
Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes. J Biochem (1965) 1.97
Conservation of genes and their organization in the chromosomal replication origin region of Bacillus subtilis and Escherichia coli. EMBO J (1985) 1.96
The effect of spo0 mutations on the expression of spo0A- and spo0F-lacZ fusions. Mol Gen Genet (1986) 1.89
Preservation of the bone mineral density of the femur after surface replacement of the hip. J Bone Joint Surg Br (2004) 1.88
Location and characterization of autonomously replicating sequences from chromosome VI of Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.88
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol (2001) 1.85
Asymmetric bidirectional replication of Bacillus subtilis chromosome. Nat New Biol (1973) 1.81
Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol (1997) 1.81
A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. J Pathol (2008) 1.78
Nucleotide sequences at the termini of phi 29 DNA. Proc Natl Acad Sci U S A (1981) 1.76
Schwannoma of the esophagus: a case exhibiting high 18F-fluorodeoxyglucose uptake in positron emission tomography imaging. Dis Esophagus (2009) 1.75
Identification of a suppressor sequence for DNA replication in the replication origin region of the Bacillus subtilis chromosome. Proc Natl Acad Sci U S A (1982) 1.75
Structure of the dnaA region of Pseudomonas putida: conservation among three bacteria, Bacillus subtilis, Escherichia coli and P. putida. Mol Gen Genet (1989) 1.72
Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest (1994) 1.69
Characterization of bovine parainfluenza virus type 3. Microbiol Immunol (1979) 1.68
Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J Virol (1999) 1.66
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol (2001) 1.63
Homeobox protein Hex induces SMemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element. Circ Res (2001) 1.61
Obesity and lipid profiles in middle aged men and women in Tanzania. East Afr Med J (2002) 1.60
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer (2007) 1.60
Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer (1998) 1.57
In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol (1998) 1.55
Structure of the dnaA region of Micrococcus luteus: conservation and variations among eubacteria. Gene (1990) 1.55
Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA. Int J Cancer (1988) 1.53
Mutational analysis of human papillomavirus type 16 E7 functions. J Virol (1990) 1.52
Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res (2006) 1.52
Variation in the photochemical reactivity of thymine in the DNA of B. subtilis spores, vegetative cells and spores germinated in chloramphenicol. Photochem Photobiol (1966) 1.52
Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J (2000) 1.51
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer (2013) 1.50
Heterogeneous DNof simian virus 40. Fed Proc (1970) 1.50
Topography of chromosome membrane junction in Bacillus subtilis. Nat New Biol (1973) 1.50
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications (2001) 1.49
Defective bacteriophage PBSH in Bacillus subtilis. II. Intracellular development of the induced prophage. J Virol (1969) 1.49
Change of DNA near the origin of replication enhances the transforming capacity of human papovavirus BK. J Virol (1982) 1.49
Detection of HTLV-I antigen in peripheral and cord blood lymphocytes from carrier mothers. Lancet (1991) 1.48
T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int (2008) 1.48
The initiation of DNA replication in Bacillus subtilis. Proc Natl Acad Sci U S A (1967) 1.48
Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. J Gastroenterol (1998) 1.47
Intraoperative extracorporeal autogenous irradiated bone grafts in tumor surgery. Clin Orthop Relat Res (1999) 1.47
Cloning of an autonomously replicating sequence (ars) from the Bacillus subtilis chromosome. Mol Microbiol (1992) 1.46
Determination of antipituitary antibody in patients with endocrine disorders by enzyme-linked immunosorbent assay and Western blot analysis. J Lab Clin Med (1998) 1.46
Biological and biochemical studies of African green monkey lymphotropic papovavirus. J Virol (1982) 1.46
Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia. Atherosclerosis (2000) 1.46
Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A. Acta Neuropathol (1996) 1.46
IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. J Immunol (1992) 1.45
Differences in the locations and modes of labral tearing between dysplastic hips and those with femoroacetabular impingement. Bone Joint J (2013) 1.44
Inguinal lymphadenopathy due to metal release from a prosthesis. A case report. J Bone Joint Surg Br (1993) 1.44
Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res (1995) 1.44
Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J Virol (2001) 1.44
Human herpesvirus 8 DNA is rarely found in Bowen's disease of non-immunosuppressed patients. Br J Dermatol (1997) 1.43
Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett (2001) 1.43
Calcium hydroxyapatite ceramic implants in bone tumour surgery. A long-term follow-up study. J Bone Joint Surg Br (2004) 1.42
High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer (2007) 1.42